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Objectives: The objective of this study was to evaluate factors associated with health-
related quality of life (HRQOL) among patients receiving home mechanical ventilation
(HMV).
Methods: Observational, cross-sectional study. Patients receiving HMV were recruited
from hospital outpatients facilities at five participating centers; a single follow-up visit
was scheduled. The Spanish version of the Severe Respiratory Insufficiency (SRI)
Questionnaire was used and the following variables were collected: socio-demographic
status, previous medical history (Charlson-Age Comorbidity Index), current symptoms,
administration of questionnaires, pulmonary function tests (PFT), current ventilatory
support, and oxygen therapy.
Results: One hundred and fifteen patients (57 males and 58 females, mean age 62713
years) were investigated. The reasons for HMV were as follows: thoracic cage
abnormalities (33 patients), obesity hypoventilation syndrome (37 patients), neuromus-
cular disorders (18 patients), sequelae of tuberculosis (12 patients), and chronic
obstructive pulmonary disease (15 patients). In a bivariate approach, dyspnea, the
number of hospitalizations, and the number of emergency room admissions in last year
were the main predictors of each HRQOL dimension. Multivariate analysis showed that
dyspnea, FEV1/FVC, and the number of hospitalizations in the previous year were
independently associated with HRQOL.Elsevier Ltd. All rights reserved.
013164; fax: +34 955013168.
(J.L. Lo´pez-Campos).
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J.L. Lo´pez-Campos et al.606Conclusions: HRQOL of patients receiving HMV is influenced by many factors, especially by
dyspnea and the number of admissions. An obstructive pattern in the PFT also influences
HRQOL. These findings may have therapeutic implications.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Health-related quality of life (HRQOL) is particularly useful
as an outcome measure in studies of chronic disorders. In
this setting, improvement of symptoms as well as patient
well-being and functioning are among the main treatment
goal achievements. Accordingly, interest in HRQOL of
patients receiving home mechanical ventilation (HMV) has
risen considerably in recent years.1 In this regard, HMV may
affect a variety of physical and psychological health
domains, and HRQOL measures could provide a broad
picture of this impact.
Besides the underlying etiology leading to HMV, patients
in this group face unique challenges such as the dependence
on external device for daily life, the number of hours spent
on ventilation, limited possibilities to work/pursue daily
activities, as well as subtle changes in disease progression
among subjects with neuromuscular disorders. These factors
are especially relevant to a chronic and impairing condition
such as HMV. Thus far, however, little data are available on
how these variables may affect HRQOL in this patient
group.2–4 In the past, the lack of reliable and valid patient-
reported outcome instruments for HMV, including HRQOL
instruments, has greatly complicated the clinical decision-
making process. Indeed, no validated disease-specific
measures were previously available to evaluate quality of
life in HMV subjects. In recent years, however, the Severe
Respiratory Insufficiency (SRI) Questionnaire, a specifically
designed instrument which aims at assessing the effects of
HMV on HRQOL, has become available5 and has been
previously translated and validated in the Spanish lan-
guage.6,7
In this study, we sought to extend knowledge of the
factors influencing HRQOL in HMV patients by using the
Spanish version of the SRI Questionnaire. A better under-
standing of these issues is crucial to improve quality of care
in this patient group and optimize clinical outcomes.Methods
Participants
Five centers in Spain participated in this observational,
cross-sectional study. The participating institutions were
the Virgen del Rocı´o University Hospital, Seville (center 1),
the Puerta del Mar University Hospital, Ca´diz (center 2), the
Virgen Macarena University Hospital, Sevilla (center 3), the
San Pedro Alca´ntara University Hospital, Ca´ceres (center 4),
and the Juan Ramo´n Jimenez Hospital, Huelva (center 5).
Patients receiving HMV were recruited from hospital out-
patient facilities at the participating centers. The study was
approved by our Institutional Review Board and all partici-
pants gave written informed consent.Adult patients receiving non-invasive HMV who were both
clinically stable and well adapted for at least 3 months met
the inclusion criteria. Exclusion criteria were as follows:
unwillingness to participate, history of exacerbation during
the last 3 months, and invasive HMV with tracheostomy. A
single follow-up visit was scheduled. During this consulta-
tion, we recorded medical and socio-demographic data.
Additionally, we administered the Spanish version of the SRI
Questionnaire. The set of socio-demographic factors in-
cluded age, gender, level of education (no education,
incomplete compulsory schooling, complete compulsory
schooling, high school, and university), and employment
status (housewife, pensioner, disabled, and others). The
extent of smoking history was measured in pack years. The
primary diagnosis and comorbidities were used to calculate
the Charlson-Age Comorbidity Index,8 a validated index used
to predict 10-year mortality. The previous performance
status was assessed according to the British Thoracic Society
guidelines (normal activity without restriction; strenuous
activity limited, can do light; limited activity but capable of
self-care; limited activity, limited self-care; confined to
bed/chair, no self-care; no record).9 Dyspnea was measured
using the British Medical Research Council Scale.10
Quality of life
The SRI Questionnaire is a 49-item self-administrated quality
of life instrument which has been translated and validated in
the Spanish language.6,7 Patients rated, on a 5-point Likert
scale (1 ¼ strongly disagree, 5 ¼ strongly agree), their agree-
ment with each of 49 statements. Subjects completed the SRI
based upon their health status during the previous week. The
SRI Questionnaire measures seven different health concepts
related to chronic respiratory failure, namely ‘Respiratory
Complaints’ (RC; 8 items), ‘Physical Functioning’ (PF; 6 items),
‘Attendant Symptoms and Sleep’ (AS; 7 items), ‘Social
Relationships’ (SR; 6 items), ‘Anxiety’ (AX; 5 items), ‘Psycho-
social Well-Being’ (WB; 9 items), and ‘Social Functioning’ (SF;
8 items). Each item belonged to a single scale.
After item recoding, a crude punctuation for each scale
was calculated. The final punctuation (or Summary Scale,
SS) was calculated as the arithmetic mean of the values in
each scale. The final SS ranges from 0 to 100, higher scores
reflecting a better HRQOL. After clearing doubts, if any, the
patients were asked to fill in the SRI Questionnaire. Patients
were told to be sincere and autonomous, and were
encouraged to self-administer the questionnaire. For those
who could not read or had trouble reading, the items were
read out and the response recorded by the investigator.
Data analysis
Statistical computations were performed with the Statistical
Package for Social Sciences (SPSS Inc., Chicago, IL) version
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Table 1 Characteristics of the study participants
(categorical variables).
Variable N %
Male gender (n ¼ 115) 57 49.6
Level of education (n ¼ 111)
No education 12 10.8
Incomplete compulsory schooling 40 36
Complete compulsory schooling 42 37.8
High school 14 12.6
University 3 2.7
Employment status (n ¼ 111)
Housewife 26 23.4
Pensioner 34 30.6
Disabled 45 40.5
Other 6 5.4
Smoking history (n ¼ 113)
Active smokers 5 4.4
Ex-smokers 39 34.5
Non-smokers 69 61.1
Performance status (n ¼ 115)
Normal activity without restriction 20 17.4
Strenuous activity limited, can do light 41 35.7
Limited activity, but capable of self-care 21 18.3
Quality of life in home mechanical ventilation 60714.0. For descriptive purposes, the mean7SD was used for
quantitative variables. The absolute and relative frequen-
cies of each category were used for qualitative data, using
the corrected values for lost data. Parametric tests were
used for comparative analysis. To compare quantitative
variables, the unpaired Student’s t-test was used. Variance
similitude was previously studied with the Levene test. To
study quantitative differences with more than two cate-
gories, ANOVA test was used and completed with a post-hoc
study using the Bonferroni’s correction to detect intergroup
differences. Qualitative variables were analyzed using the
Chi-square test and Fisher’s exact test when the expected
frequency waso5. Pearson’s coefficients were used to study
correlations between quantitative variables.
In order to assess the relationships between HRQOL and
other factors, multiple stepwise linear regression analysis
was performed, where the dependent variable was each of
the HRQOL dimensions. Variables either statistically
(po0.10) associated with each other or clinically relevant
according to literature were selected for covariate control
as independent variables. For the purpose of this analysis,
ordered categorical variables were transformed into dichot-
omous dummy variables. An acceptable alpha error was set
at 0.05.Limited activity, limited self-care 19 16.5
Confined to bed/chair, no self-care 5 4.3
No record 9 7.8
Main diagnosis (n ¼ 115)
Thoracic cage abnormalities 33 28.7
Obesity hypoventilation syndrome (OHS) 37 32.2
Neuromuscular disorders 18 15.7
Sequelae of tuberculosis (ST) 12 10.4
Chronic obstructive pulmonary disease (COPD) 15 13.0
Participating center (n ¼ 115)
Center 1 11 9.6
Center 2 18 15.7
Center 3 33 28.7
Center 4 43 37.4
Center 5 10 8.7
Hospitalization in the last year (n ¼ 97)
No admission 65 67
One admission 16 16.5
More than one admission 16 16.5
Emergency room in the last year (n ¼ 97)
No attendance 74 76.3
One attendance 14 14.4
More than one attendance 9 9.3
Self-administration of the questionnaire (n ¼ 115) 63 54.8
Morning headache (n ¼ 115) 38 33
Daytime sleepiness (n ¼ 115) 93 80.9
Type of mask (n ¼ 108)
Nasal 103 95.3
Oronasal 5 4.6
Type of ventilation (n ¼ 109)
Pressure 88 80.7
Volume 21 19.3
Long-term oxygen therapy (n ¼ 115) 13 11.3
Oxygen during HMV (n ¼ 115) 53 46.1
As defined in the text. HMV, home mechanical ventilation.Results
One hundred and fifteen patients (57 males and 58 females,
mean age 62713 years) were investigated. The character-
istics of the study population are shown in Tables 1–3. The
reasons for HMV were as follows: thoracic cage abnormal-
ities (33 patients), obesity hypoventilation syndrome (OHS)
(37 patients), neuromuscular disorders (18 patients), seque-
lae of tuberculosis (TBS; 12 patients), and chronic obstruc-
tive pulmonary disease (COPD; 15 patients). Sixty-three
(46.1%) patients required supplemental oxygen during
ventilation (mean flow: 1.670.6 L/min), whereas 13
(11.3%) participants were on long-term oxygen therapy
(mean flow: 1.570.5 L/min). All patients in this study were
well adapted to HMV and all showed no or minor adverse
effects. Pulmonary function tests (PFT) were different
between diagnostic groups (Table 3). Those patients with
an obstructive component (CODP and TBS) had a lower FEV1
than the rest of the sample (obstructive 35713.9 vs. non-
obstructive 46.2719.3; p ¼ 0.014).
The SRI scores in different domains were as follows: RC,
61.2722.1; PF, 43.2726.7; AS, 60.9721.6; SR, 76.7717.2;
AX, 55.9724.8; WB, 58.3722.7; FS, 54.9725.8; and SS,
57.8718.5. Results of bivariate analyses for the main
categorical variables are shown in Table 4. Psychometric
scale values were not significantly different between
genders (SRI-SS: 29719 in males vs. 56718 in females;
p ¼ n.s.), the only exceptions being SRI-RC (55722 in males
vs. 67721 in females; p ¼ 0.005) and SRI-AX (50723 in
males vs. 62725 in females; p ¼ 0.012). None of the scales
had a significant association with either education level or
employment status. No effect of mode of questionnaire
administration was seen on scores of different scales. Age,
Charlson-age index, BMI, and questionnaire administration
time were not significantly different between scales. With
regard to lung function tests, we observed no significant
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J.L. Lo´pez-Campos et al.608effects of FVC, pH, and pO2. Compared to other centers,
centers 1 and 4 obtained higher punctuations on the SRI-RC,
SRI-SR, SRI-AX, SRI-FS, and SRI-SS (po0.05) scales. However,
these differences were likely to be non-influential in the
multivariate model. Significant differences between diag-
nostics groups are represented in Figure 1. Dyspnea, the
number of hospitalizations, and the number of emergencyTable 2 Characteristics of the study participants
(continuous variables).
Variables Mean SD
Sociodemographic
Age (n ¼ 113) 61.9 13.9
Medical history
Smoking (pack-years, n ¼ 40) 38.2 25.2
Charlson Age-Comorbidity Index
(n ¼ 115)
3.6 1.3
Admissions (n ¼ 97) 0.41 1.03
BMI (n ¼ 71) 33.1 8.1
Mode of administration of the SRI Questionnaire
Administration time (minutes,
n ¼ 100)
10.9 5.4
Symptoms
Dyspnea by MRC scale (n ¼ 115) 2.1 1.3
Pulmonary function tests
FVC (mL) (n ¼ 75) 1401 688
FVC (%) (n ¼ 81) 48 17.8
FEV1 (mL) (n ¼ 75) 980 520
FEV1 (%) (n ¼ 82) 43 18.6
FEV1/FVC (%) (n ¼ 80) 68.6 14.8
pH (n ¼ 95) 7.40 0.05
pO2 (mmHg) (n ¼ 98) 68.3 13.9
pCO2 (mmHg) (n ¼ 98) 46.7 7.9
Ventilation
HMV (hours/day) (n ¼ 113) 8.6 3.2
HMV (months) (n ¼ 114) 55.3 49
As defined in the text. SD, standard deviation; BMI, body
mass index; admissions, number of admissions in the previous
year; FVC, forced vital capacity; FEV1, forced expiratory
volume in one second; pO2, partial pressure of oxygen in
arterial blood; pCO2, partial pressure of carbon dioxide in
arterial blood; HMV, home mechanical ventilation.
Table 3 Functional parameters between diagnostic groups.
Parameter Thoracic cage OHS Neuromuscula
n (%) 33 (28.6%) 37 (32.1%) 18 (15.6%)
FVC (%) 36713 66716 44715
FEV1 (%) 33712 58718 44716
FEV1/FVC 72711 74712 74720
pH 7.3970.04 7.4170.04 7.4270.08
pCO2 4778 4577 4376
pO2 70721 6579 7679
OHS, obesity hypoventilation syndrome; COPD, chronic obstructive proom admissions in last year were the main predictors of
each HRQOL dimension (the only exception being admissions
in the previous year and the WB subscale). Dyspnea
correlated significantly with all the SRI components with
correlation coefficients ranging from 0.2 to 0.5 (po0.05
for all correlations).
The results of multivariate analysis for each HRQOL
dimension are shown in Table 5. All seven dimensions of
the HRQOL appeared to be similarly affected by dyspnea.
The final model indicated that dyspnea, FEV1/FVC, and the
number of hospitalizations in the previous year were
independent predictors of HRQOL in our study cohort.Discussion
This study found that HRQOL is significantly impaired in HMV
patients and that the most significant characteristics
independently associated with HRQOL were dyspnea, an
obstructive pattern on PFT, and the number of hospitaliza-
tions in the previous year.
Patients receiving HMV delivered non-invasively via a
mask constitute a heterogeneous group by their underlying
pathology. In this regard, it is well established that patients
with chest wall deformity, neuromuscular disease, or COPD
may benefit from this treatment.11 In recent years,
measuring the impact of HMV treatment on patient’s HRQOL
has become increasingly recognized as an important out-
come measure.4 Nonetheless, the majority of studies
examining quality of life in HMV patients have used generic
questionnaires such as the Short Form 36 (SF 36), or
measures specifically designed for patients with COPD.2,12
Few studies have been published to date with the use of
HMV-specific HRQOL measures. Under these circumstances,
the SRI Questionnaire has been developed as a multi-
dimensional HMV-specific HRQOL assessment tool with
robust psychometric properties.5 In this regard, the original
German version has been transculturally adapted and
validated in the Spanish language.6,7
Numerous patients in our study (32.2%) had obesity
hypoventilation syndrome. This observation might explain
the high BMI as observed in our study. It is conceivable that
most of our study variables could be influenced by the
distribution of underlying diseases in our series. However,
we are confident that the study group is representative of
the population in our area, in keeping with the studies by de
Lucas Ramos et al.13 and Lo´pez et al.14r Tuberculosis sequelae COPD Total
12 (10.4%) 15 (13.3%) 115 (100%)
46716 65710 48717
36711 34716 43718
5977 53712 68714
7.4070.02 7.3670.02 7.4070.05
4776 52711 4778
6578 64712 68714
ulmonary disease; HMV, home mechanical ventilation.
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Figure 1 Mean score among diagnostic categories.
Table 4 Relationships between different SRI dimensions and categorical variables.
Variables SRI- RC SRI-PF SRI-AS SRI-SR SRI-AX SRI-WB SRI-FS SRI-SS
Emergency room in the last year
No
attendance
65.5721.8 50727 63.2720 82.1715.7 61.9725.5 65.2722 62725.6 63.8717.8
One
attendance
47.9725.9 31.3721.9 55.7725.4 68.7715.7 46.5724.6 47717.6 42.7720 44.4711.6
More than
one
attendance
53.9719.9 26719.2 50.4723.1 69.8719.4 44723.2 40.7723.4 36.2722.8 40.5713
p-value 0.012 0.001 0.086 0.003 0.011 o0.001 0.003 o0.001
Hospitalization in the last year
No admission 63.2723.4 47.2727.3 62.9720.3 80.9716 60.8726.3 61.7723.3 59.9726.4 61.9717.9
One
admission
46.1720 29.4722.7 48.3724.5 65.3719.1 35.7720.7 48723.9 38722.7 40.7715.6
More than
one
admission
61.4718.8 35.6726.6 55.1727.5 76.1717.4 54.4714.8 53.3723.3 48.2716.6 56.9719
p-value 0.049 0.053 0.068 0.010 0.003 ns 0.023 0.005
ICS, incomplete compulsory schooling; CCS, complete compulsory schooling; OHS, obesity hypoventilation syndrome; COPD, chronic
obstructive pulmonary disease; ns, not significant; SRI, Severe Respiratory Insufficiency; RC, Respiratory Complaints; PF, Physical
Functioning; AS, Attendant Symptoms and Sleep; SR, Social Relationships; AX, Anxiety; WB, Psychosocial Well-Being; SF, Social
Functioning; SS, Summary Scale.
Quality of life in home mechanical ventilation 609The association between dyspnea and worse HRQOL in all
SRI scales is of major interest and is in keeping with previous
data.15,16 It has been already established that dyspnea is
related to lung function and may explain exercise limita-
tion.17 However, limited exercise capacity may be present
even in patients without severe functional impairment.18 In
this regard, other factors such as muscular and cardiovas-cular deconditioning may influence exercise capacity,
dyspnea perception, and HRQOL.19,20 It is thus posited that
specific rehabilitation programs may have beneficial effects
on HRQOL beyond those achieved by optimal medical
therapy and ventilatory support.
Considerable evidence has now accrued to suggest that
rehabilitation programs may improve exercise capacity,
ARTICLE IN PRESS
Table 5 Multivariate analysis of HRQOL dimensions.
Dimension Model summary Variables in the model b (95% CI) p-value
SRI-RC R2 ¼ 0.789 Neuromuscular 7.1 (16.4 to 30.4) ns
po0.001 COPD 4.6 (11.1 to 20.4) ns
OHS 21.6 (3.1–40.1) 0.023
ST 3.4 (19.8 to 26.5) ns
Long-term oxygen therapy 25.4 (49.7 to 1.1) 0.041
Dyspnea 7.1 (12.3 to 1.8) 0.010
Pack-years 0.3 (0.5 to 0) 0.050
SRI- PF R2 ¼ 0.511 Emergency room 6.6 (11.9 to 1.3) 0.017
po0.001 Dyspnea 8.8 (13.6 to 4.0) 0.001
FVC 0.3 (0.03–0.6) 0.032
Oxygen while ventilation 12.6 (23.5 to 1.7) 0.024
Admissions 8.6 (0.5 to 17.8) 0.064
Performance status 3.9 (8.7 to 0.8) 0.101
SRI-AS R2 ¼ 0.569 Dyspnea 7.8 (11.9 to 3.7) 0.001
po0.001 Long-term oxygen therapy 21.7 (41.9 to 1.4) 0.036
Admissions 3.9 (0.3–7.4) 0.033
Pack-years 0.025 (0.2 to 0.2) 0.810
SRI-SR R2 ¼ 0.480 Dyspnea 5.9 (10.4 to 1.4) 0.012
p ¼ 0.004 Long-term oxygen therapy 19.7 (0.5–39) 0.045
Age 0.5 (0.03–0.9) 0.037
Emergency room in the last year 12.3 (20.6 to 3.9) 0.005
Performance status 5.8 (0.6–11) 0.028
Pack-years 0.9 (0.3 to 0.1) 0.344
SRI-AX R2 ¼ 0.348 Dyspnea 4.7 (8.5 to 0.9) 0.014
po0.001 FEV1 0.4 (0.13–0.6) 0.003
Gender 9.5 (0.3–18.7) 0.043
Age 0.5 (0.04–0.9) 0.033
SRI-WB R2 ¼ 0.428 Age 0.34 (0.004 to 0.6) 0.053
po0.001 Dyspnea 6.3 (9.6 to 2.9) o0.001
Oxygen during ventilation –9.6 (–18.1 to 1.08) 0.028
Time for SRI administration 1.09 (1.9 to 2.9) 0.008
Emergency room visits 8.11 (12.5 to 3.6) 0.001
SRI-SF R2 ¼ 0.501 Pack-years 0.3 (0.6 to 0.04) 0.027
po0.001 Dyspnea 8.5 (13.4 to 3.6) 0.001
Oxygen during ventilation 13.1 (27 to 0.7) 0.064
SRI-SS R2 ¼ 0.661 Admissions in the previous year 4.6 (1.1–8.2) 0.015
p ¼ 0.001 Dyspnea 8.5 (13.3 to 3.7) 0.002
FEV1/FVC 0.5 (0.04–0.9) 0.036
Pack-years 0.040 (0.4 to 0.3) ns
RC, Respiratory Complaints; PF, Physical Functioning; AS, Attendant Symptoms and Sleep; SR, Social Relationships; AX, Anxiety; WB,
Psychosocial Well-Being; SF, Social Functioning; SS, Summary Scale. R2: determination coefficient; b: multiple correlation coefficient.
J.L. Lo´pez-Campos et al.610dyspnea, HRQOL and, possibly, survival time in selected
patients with chronic lung disease.21–23 Foglio et al. have
previously shown that COPD patients undergoing repeated
rehabilitation program do not show any significant worsen-
ing in exercise tolerance, dyspnea and HRQL along a period
of 7 years.24 It is thus tempting to speculate that training
programs of subjects requiring HMV may improve HRQOL in
this patient group. Although no published data are currently
available in support to our hypothesis, the effects of a
rehabilitation program in patients with kyphoscoliosis are
currently under investigation in our institutions.25 Althoughsubject to future confirmation, we speculate that exercise
capacity may significantly affect HRQOL in HMV patients.
In our study, the number of hospitalizations or emergency
room attendance was associated with a lower score in
several HRQOL dimensions. Thus far, this relationship has
been poorly explored. In this regard, Rebollo et al.26 have
previously shown that a higher number of admission was
related to worse HRQOL scores in hemodialysis patients,
even after allowance for potential confounders. Addition-
ally, Soler et al.27 have suggested that the use of a simple
program—comprising an educational schema and regular
ARTICLE IN PRESS
Quality of life in home mechanical ventilation 611clinical monitoring—in selected COPD patients with a
history of frequent exacerbations, may produce a significant
reduction in the number of hospital admissions, as well as in
an improvement of HRQL and prognosis.
Previous findings in the literature support the notion that
PFT are not associated with HRQOL in patients with chronic
respiratory disease.28 Accordingly, a study in patients with
pulmonary fibrosis has clearly demonstrated that none of
the quality of life dimensions was significantly related to the
lung function parameters.29 In our study, however, an
obstructive pattern on PFT was an independent predictor
influencing HRQOL of patients receiving HMV. This finding is
in keeping with Euteneuer et al.1 who found better HRQOL
scores in patients with restrictive respiratory diseases than
in those with obstructive diseases. Moreover, our data
support the growing idea that the degree of impairment in
quality of life is different in obstructive (COPD and TBS) vs.
restrictive lung disease.30
It is well known that several HMV patients may have
difficulty tolerating nasal masks due to nasal airway
problems, mouth leak, and general discomfort from the
mask and headgear. These limitations may be overcome by
an oronasal mask. Besides, the overall number of hours of
ventilation may be related to the severity and the under-
lying cause of respiratory failure. In this regard, neuromus-
cular patients may require prolonged mechanical ventilation
compared to HMV patients with different etiologies.
Although the type of mask and the overall number of hours
of ventilation were significantly associated with HRQOL in
bivariate analysis, these associations disappeared after
allowance for potential confounders. This could be ex-
plained by the adoption of coping strategies that may
eventually help the patients to overcome the overall
burden, as described by Janssens et al.31
Long-term oxygen therapy has previously been shown to
be associated with HRQL in COPD patients.16 In our study,
bivariate analysis showed that patients receiving this
treatment experienced an impaired HRQL. Interestingly,
long-term oxygen therapy was found to be independently
associated with the SRI-RC, SRI-AS, and SRI-SR scales in
multivariate analysis. Additionally, an association between
the use of oxygen during ventilation and the SRI-PF, SRI-WB,
and SRI-SF scales was evident. This association has not been
previously described and deserves further investigation.
There has been considerable debate on the reliability of
self-administered questionnaires and a consensus has not
been achieved. In their classical study, Cook et al.32 found
that self-administered tools showed systematically greater
HRQOL impairment compared to interviewer-administered
questionnaires. In contrast, Miller et al.33 have recently
suggested that more favorable measures of self-reported
functional status and well-being may be expected from
clinic administrations of rating instruments. In our present
study, the HRQOL instruments were administered in a
clinical setting, but about half of the SRI questionnaires
were self-rated. The mode of administration did not
influence the measures of HRQOL status obtained from the
SRI questionnaires, as demonstrated using bivariate and
multivariate analyses.
Taken together, our findings demonstrate that dyspnea,
an obstructive pattern on PFT, and the number of
hospitalizations in the previous year are the main factorsinfluencing HRQOL of patients receiving HMV. These findings
may have implications in the clinical management of this
patient group and may be useful for the design of specific
therapeutic targets for these patients such as rehabilitation
programs.
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